ゼリア新薬工業の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/11/22 | 2,239 | 2,252 | 2,222 | 2,244 | +23 | +1% | 37,100 |
| 2024/11/21 | 2,238 | 2,247 | 2,221 | 2,221 | +5 | +0.2% | 24,500 |
| 2024/11/20 | 2,222 | 2,236 | 2,215 | 2,216 | ±0 | ±0% | 29,900 |
| 2024/11/19 | 2,226 | 2,227 | 2,210 | 2,216 | ±0 | ±0% | 23,100 |
| 2024/11/18 | 2,203 | 2,236 | 2,203 | 2,216 | -13 | -0.6% | 27,600 |
| 2024/11/15 | 2,256 | 2,256 | 2,220 | 2,229 | -2 | -0.1% | 26,600 |
| 2024/11/14 | 2,260 | 2,265 | 2,231 | 2,231 | -29 | -1.3% | 37,800 |
| 2024/11/13 | 2,236 | 2,271 | 2,230 | 2,260 | +20 | +0.9% | 61,100 |
| 2024/11/12 | 2,229 | 2,258 | 2,229 | 2,240 | +19 | +0.9% | 54,900 |
| 2024/11/11 | 2,217 | 2,230 | 2,203 | 2,221 | +4 | +0.2% | 46,000 |
| 2024/11/08 | 2,274 | 2,279 | 2,204 | 2,217 | -38 | -1.7% | 91,700 |
| 2024/11/07 | 2,239 | 2,298 | 2,221 | 2,255 | -117 | -4.9% | 229,100 |
| 2024/11/06 | 2,372 | 2,397 | 2,348 | 2,372 | -3 | -0.1% | 95,200 |
| 2024/11/05 | 2,315 | 2,411 | 2,297 | 2,375 | +71 | +3.1% | 209,900 |
| 2024/11/01 | 2,315 | 2,330 | 2,294 | 2,304 | -26 | -1.1% | 44,300 |
| 2024/10/31 | 2,341 | 2,360 | 2,313 | 2,330 | +4 | +0.2% | 77,300 |
| 2024/10/30 | 2,343 | 2,347 | 2,316 | 2,326 | +4 | +0.2% | 283,300 |
| 2024/10/29 | 2,308 | 2,339 | 2,300 | 2,322 | +14 | +0.6% | 50,300 |
| 2024/10/28 | 2,288 | 2,318 | 2,287 | 2,308 | +20 | +0.9% | 31,600 |
| 2024/10/25 | 2,319 | 2,319 | 2,276 | 2,288 | -26 | -1.1% | 39,600 |
| 2024/10/24 | 2,302 | 2,323 | 2,292 | 2,314 | +2 | +0.1% | 37,500 |
| 2024/10/23 | 2,305 | 2,326 | 2,303 | 2,312 | +1 | ±0% | 36,500 |
| 2024/10/22 | 2,326 | 2,337 | 2,311 | 2,311 | -15 | -0.6% | 39,200 |
| 2024/10/21 | 2,360 | 2,360 | 2,326 | 2,326 | -22 | -0.9% | 27,800 |
| 2024/10/18 | 2,333 | 2,354 | 2,326 | 2,348 | +23 | +1% | 32,500 |
| 2024/10/17 | 2,360 | 2,369 | 2,321 | 2,325 | -30 | -1.3% | 38,400 |
| 2024/10/16 | 2,340 | 2,369 | 2,337 | 2,355 | +5 | +0.2% | 47,700 |
| 2024/10/15 | 2,357 | 2,357 | 2,335 | 2,350 | +11 | +0.5% | 44,500 |
| 2024/10/11 | 2,360 | 2,361 | 2,329 | 2,339 | -18 | -0.8% | 49,300 |
| 2024/10/10 | 2,350 | 2,357 | 2,331 | 2,357 | +20 | +0.9% | 34,300 |
| 2024/10/09 | 2,350 | 2,360 | 2,331 | 2,337 | -5 | -0.2% | 55,900 |
| 2024/10/08 | 2,323 | 2,348 | 2,314 | 2,342 | +4 | +0.2% | 60,200 |
| 2024/10/07 | 2,340 | 2,354 | 2,322 | 2,338 | +14 | +0.6% | 60,800 |
| 2024/10/04 | 2,314 | 2,338 | 2,314 | 2,324 | +17 | +0.7% | 61,600 |
| 2024/10/03 | 2,310 | 2,314 | 2,292 | 2,307 | +32 | +1.4% | 52,300 |
| 2024/10/02 | 2,284 | 2,310 | 2,264 | 2,275 | -8 | -0.4% | 71,600 |
| 2024/10/01 | 2,253 | 2,283 | 2,240 | 2,283 | +13 | +0.6% | 54,000 |
| 2024/09/30 | 2,228 | 2,271 | 2,222 | 2,270 | +14 | +0.6% | 85,800 |
| 2024/09/27 | 2,228 | 2,268 | 2,218 | 2,256 | -7 | -0.3% | 82,600 |
| 2024/09/26 | 2,241 | 2,273 | 2,236 | 2,263 | +27 | +1.2% | 250,500 |
| 2024/09/25 | 2,228 | 2,244 | 2,220 | 2,236 | +6 | +0.3% | 108,900 |
| 2024/09/24 | 2,253 | 2,261 | 2,230 | 2,230 | -17 | -0.8% | 119,800 |
| 2024/09/20 | 2,244 | 2,267 | 2,224 | 2,247 | +24 | +1.1% | 133,500 |
| 2024/09/19 | 2,249 | 2,257 | 2,212 | 2,223 | -14 | -0.6% | 98,600 |
| 2024/09/18 | 2,216 | 2,238 | 2,215 | 2,237 | +23 | +1% | 62,800 |
| 2024/09/17 | 2,203 | 2,216 | 2,186 | 2,214 | +21 | +1% | 75,800 |
| 2024/09/13 | 2,208 | 2,222 | 2,181 | 2,193 | -39 | -1.7% | 73,000 |
| 2024/09/12 | 2,235 | 2,257 | 2,223 | 2,232 | +22 | +1% | 53,300 |
| 2024/09/11 | 2,250 | 2,250 | 2,201 | 2,210 | -54 | -2.4% | 52,700 |
| 2024/09/10 | 2,265 | 2,285 | 2,257 | 2,264 | -1 | ±0% | 41,700 |
1～
50
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「ゼリア新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ゼリア新薬 | 224,400円 | +13.6% | +29.2% | 2.05% | 11.64倍 | 1.12倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| 鳥居薬 | 476,000円 | +12.0% | +28.1% | 2.52% | 26.24倍 | 1.11倍 |
|
ＪＴ傘下。柱の抗ＨＩＶ薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
| 持田薬 | 331,500円 | +3.0% | +27.5% | 2.41% | 20.99倍 | 0.91倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| ネクセラファーマ | 113,200円 | +197.7% | - | 0.00% | 46.26倍 | 1.48倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
| 杏林製薬 | 149,900円 | +3.2% | +4.5% | 3.47% | 17.22倍 | 0.66倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
市場注目の銘柄
チャート関連のコラム
